In general, estrogen is thought to enhance the efficacy of antipsychotics and has been used clinically as an effective adjunctive treatment for schizophrenia [63,64,65,66]; more often, a selective estrogen receptor modulator (SERM) such as raloxifene is used [66], to avoid estrogen adverse effects. This evidence concerns the gene ESR1 and schizophrenia.